Nicholas Rebold

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Pseudomonas Aeruginosa

Multidrug Resistant

Acinetobacter Baumannii

Top Venues

Pharmacotherapy

Microbiology spectrum

Open forum infectious diseases

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy 44 (3) (2024)
Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy (2024)
Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy 44 (3) (2024)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne, Amer El Ghali, Kaylee E Caniff, Michael P Veve, Michael Joseph Rybak
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology spectrum 11 (1) (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Dana J Holger, Nicholas Rebold, Michael J Rybak
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious diseases and therapy 11 (2) (2022)
Nicholas Rebold, Thomas P Lodise, Michael Joseph Rybak
Panacea or oversimplification: Relating AUC and troughs. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 79 (12) (2022)
Nicholas Rebold, Michael J Rybak, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie E Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark J Biagi, Wesley D Kufel, William J Moore, Nicholas J Mercuro, Brian R Raux, Michael Joseph Rybak
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open forum infectious diseases 8 (12) (2021)